SECOR Capital Advisors, LP - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 89 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SECOR Capital Advisors, LP ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q2 2018$592,000
-21.4%
13,196
-22.3%
0.05%
-17.7%
Q1 2018$753,000
+3.2%
16,976
+0.7%
0.06%
+113.8%
Q4 2017$730,000
-7.5%
16,855
-0.7%
0.03%
-61.3%
Q3 2017$789,000
-6.1%
16,9660.0%0.08%
-1.3%
Q2 2017$840,000
-10.7%
16,966
-1.1%
0.08%
-26.2%
Q1 2017$941,000
-4.8%
17,163
-3.3%
0.10%
-14.9%
Q4 2016$988,000
-3.8%
17,740
-21.1%
0.12%
+8.0%
Q3 2016$1,027,000
+54.4%
22,489
+35.0%
0.11%
+33.3%
Q2 2016$665,000
+150.9%
16,657
+118.9%
0.08%
+133.3%
Q1 2016$265,0007,6110.04%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q2 2017
NameSharesValueWeighting ↓
JW Asset Management, LLC 73,649$3,646,0002.32%
Stonepine Capital Management, LLC 59,878$2,965,0001.60%
NORTHPOINTE CAPITAL LLC 109,644$5,428,0000.57%
Elk Creek Partners, LLC 145,406$7,199,0000.47%
TFS CAPITAL LLC 18,208$901,0000.35%
RICE HALL JAMES & ASSOCIATES, LLC 161,671$8,004,0000.35%
Ativo Capital Management LLC 19,592$970,0000.26%
Matarin Capital Management, LLC 57,034$2,823,753,0000.26%
ISTHMUS PARTNERS, LLC 16,505$817,0000.24%
Stanley-Laman Group, Ltd. 12,546$621,0000.17%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders